Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patricio Lopez-Jaramillo is active.

Publication


Featured researches published by Patricio Lopez-Jaramillo.


American Journal of Hypertension | 2016

Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans.

Pablo Lamelas; Andrew Mente; Rafael Diaz; Andres Orlandini; Alvaro Avezum; Gustavo B.F. Oliveira; Fernando Lanas; Pamela Seron; Patricio Lopez-Jaramillo; Paul Camacho-Lopez; Martin O’Donnell; Sumathy Rangarajan; Koon K. Teo; Salim Yusuf

BACKGROUND Information on actual sodium intake and its relationships with blood pressure (BP) and clinical events in South America is limited. The aim of this cohort study was to assess the relationship of sodium intake with BP, cardiovascular (CV) events, and mortality in South America. METHODS We studied 17,033 individuals, aged 35-70 years, from 4 South American countries (Argentina, Brazil, Chile, and Colombia). Measures of sodium excretion, estimated from morning fasting urine, were used as a surrogate for daily sodium intake. We measured BP and monitored the composite outcome of death and major CV events. RESULTS Overall mean sodium excretion was 4.70±1.43g/day. A positive, nonuniform association between sodium and BP was detected, with a significant steeper slope for the relationship at higher sodium excretion levels (P < 0.001 for interaction). With a median follow-up of 4.7 years, the primary composite outcome (all-cause death, myocardial infarction, stroke, or heart failure) occurred in 568 participants (3.4%). Compared with sodium excretion of 5-6g/day (reference group), participants who excreted >7g/day had increased risks of the primary outcome (odds ratio (OR) 1.73; 95% confidence interval (CI) 1.24 to 2.40; P < 0.001), as well as death from any cause (OR 1.87; 95% CI 1.23 to 2.83; P = 0.003) and major CV disease (OR 1.77; 95% CI 1.12 to 2.81; P = 0.014). Sodium excretion of <3g/day was associated with a statistically nonsignificant increased risk of the primary outcome (OR 1.20; 95% CI 0.86 to 1.65; P = 0.26) and death from any cause (OR 1.25; 95% CI 0.81 to 1.93; P = 0.29), and a significant increased risk of major CV disease (OR 1.50; 95% CI 1.01 to 2.24; P = 0.048), as compared to the reference group. CONCLUSIONS Our results support a positive, nonuniform association between estimated urinary sodium excretion and BP, and a possible J-shaped pattern of association between sodium excretion over the entire range and clinical outcomes.


Archive | 2017

Perspectiva clínica sobre el tratamiento antihipertensivo en adultos con hipertensión grado 1 y riesgo cardiovascular bajo a moderado: consulta internacional de expertos

Alberto Morales-Salinas; Antonio Coca; Michael H. Olsen; Ramiro Sanchez; Weimar K. Sebba-Barroso; Richard Kones; Vicente Bertomeu-Martínez; Javier Sobrino; Luis Alcocer; Daniel J. Piñeiro; Fernando Lanas; Carlos Alberto Machado; Fernando Aguirre Palacios; José Ortellado; Gonzalo Pérez; Rodrigo Sabio; Orlando Landrove; Delfín Rodriguez; Alfredo Dueñas-Herrera; Ayelen Rodríguez-Portelles; José Z. Parra-Carrillo; Daniel Piskorz; Alfonso Bryce Moncloa; Gabriel Waisman; Yuichiro Yano; Hector O. Ventura; Marcelo Orias; Dorairaj Prabhakaran; Johan Sundström; Ji-Guang Wang


Rev. MED | 2013

Consenso latinommericano de hipertensión en pacentes con diabetes tipo 2 y sínndrome metabólico

Patricio Lopez-Jaramillo; Ramiro Sanchez; Margarita Díaz; Leonardo Cobos; José Z. Parra-Carrillo; Fernando Lizcano; Fernando Lanas; Isaac Sinay; Iván D. Sierra; Ernesto Peñaherrera; Mario Benderky; Helena Schmid; Rodrigo Botero; Manuel Urina; Joffre Lara; Milton C. Foos; Gustavo Márquez; Stephen B. Harrap; Agustin J. Ramirez; Alberto Zanchetti


Revista mexicana de cardiología | 2017

Atherogenic dyslipidemia in Latin America: prevalence, causes and treatment. Consensus

Jesus E Isea-Perez; Fernando Lanas; Josefina Medina; José Gómez-Mancebo; Enrique Morales; Mónica Acevedo; Daniel Pirskorz; Livia Machado; Alfredo Lozada; Alfonzo Bryce; Alberto J. Lorenzatti; Carlos Carrera; Patricio Lopez-Jaramillo; Xavier Pintó; Fernando S Wyss-Quintana


Revista Venezolana de Endocrinología y Metabolismo | 2017

Dislipidemia aterogénica en Latino América: prevalencia, causas y tratamiento

Carlos I Ponte-N; Jesus E Isea-Perez; Alberto J. Lorenzatti; Patricio Lopez-Jaramillo; Fernando Stuardo Wyss-Q; Xavier Pintó; Fernando Lanas; Josefina Medina; Livia T Machado-H; Mónica Acevedo; Paola Varleta; Alfonso Bryce; Carlos Carrera; Carlos Ernesto Peñaherrera; José Ramón Gómez-M; Alfredo Lozada; Alonso Merchan-V; Daniel Piskorz; Enrique Morales; Maria Paniagua; Félix Medina-Palomino; Raul Alejandro Villar-M; Leonardo Cobos; Enrique Gómez-Alvares; Rodrigo Alonso; Juan Colan; Julio A. Chirinos; Jofre Lara; Vladimir Ullauri; Ildefonso Arocha


Revista Venezolana de Endocrinología y Metabolismo | 2017

Atherogenic dislipidemia in Latin America: prevalence, causes and treatment

Carlos I Ponte-N; Jesus E Isea-Perez; Alberto J. Lorenzatti; Patricio Lopez-Jaramillo; Fernando Stuardo Wyss-Q; Xavier Pintó; Fernando Lanas; Josefina Medina; Livia T Machado-H; Mónica Acevedo; Paola Varleta; Alfonso Bryce; Carlos Carrera; Carlos Ernesto Peñaherrera; José Ramón Gómez-M; Alfredo Lozada; Alonso Merchan-V; Daniel Piskorz; Enrique Morales; Maria Paniagua; Félix Medina-Palomino; Raul Alejandro Villar-M; Leonardo Cobos; Enrique Gómez-Alvares; Rodrigo Alonso; Juan Colan; Julio A. Chirinos; Jofre Lara; Vladimir Ullauri; Ildefonso Arocha


Archive | 2016

Clinical Research Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics

Eva Lonn; Jackie Bosch; Janice Pogue; Álvaro Avezum; Chazova Ie; Antonio Dans; Rafael Diaz; George Fodor; Petr Jansky; Matyas Keltai; Katalin Keltai; Kamlesh Kunti; Jae-Hyung Kim; Lawrence A. Leiter; Basil Lewis; Lisheng Liu; Patricio Lopez-Jaramillo; Prem Pais; Alexandr Parkhomenko; Leopoldo Soares Piegas; Christopher M. Reid; Karen Sliwa; William D. Toff; John Varigos; Denis Xavier; Khalid Yusoff; Jun Zhu; Gilles R. Dagenais; Salim Yusuf


Acta Médica Colombiana | 2016

El aporte colombo-ecuatoriano al estudio hopE-3 y a la prevención primaria cardiovascular

Patricio Lopez-Jaramillo; Dora I. Molina; Aristides Sotomayor; Jose L. Accini; Henry García; María Eugenia Casanova; Gregorio Sanchez; Roberto Quiroz; Carlos Cure-Cure; Luis García; Mario Figueredo; Gustavo Aroca; Yan Carlos Duarte; Ernesto Peñaherrera; Mónica Lopez; Mauricio Espinel; Marisol López-Pico


Archive | 2013

Prevalence,Awareness,Treatment,andControl ofHypertensioninRuralandUrbanCommunities inHigh-,Middle-,andLow-IncomeCountries

Clara K. Chow; Koon K. Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Álvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles R. Dagenais; Rafael Diaz; Khawar Abbas Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf

Collaboration


Dive into the Patricio Lopez-Jaramillo's collaboration.

Top Co-Authors

Avatar

Fernando Lanas

University of La Frontera

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xavier Pintó

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Julio A. Chirinos

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Álvaro Avezum

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

Alfonso Bryce

University of Guadalajara

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge